Piramal Pharma Limited (PPLPHARMA.BO)
INR 221.45
(2.07%)
INR 221.45
(2.07%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 178.2 Million INR | 109.56% |
| 2022 | -1.86 Billion INR | -149.6% |
| 2021 | 3.75 Billion INR | -34.22% |
| 2020 | 5.71 Billion INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 225.9 Million INR | 125.49% |
| 2024 Q1 | -886.4 Million INR | -187.53% |
| 2023 Q1 | -985.8 Million INR | -296.73% |
| 2023 FY | 178.2 Million INR | 109.56% |
| 2023 Q4 | 1.01 Billion INR | 901.68% |
| 2023 Q3 | 101.1 Million INR | 101.39% |
| 2023 Q2 | 50.2 Million INR | 105.09% |
| 2022 Q2 | -373.4 Million INR | 65.76% |
| 2022 Q1 | -1.09 Billion INR | -163.72% |
| 2022 FY | -1.86 Billion INR | -149.6% |
| 2022 Q4 | 501.1 Million INR | 155.57% |
| 2022 Q3 | -901.8 Million INR | -141.51% |
| 2021 Q2 | 365.6 Million INR | 0.0% |
| 2021 FY | 3.75 Billion INR | -34.22% |
| 2021 Q4 | 1.71 Billion INR | 4.76% |
| 2021 Q3 | 1.63 Billion INR | 346.85% |
| 2020 FY | 5.71 Billion INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 97.106% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 99.438% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 96.216% |
| Granules India Limited | 4.05 Billion INR | 95.603% |
| Indoco Remedies Limited | 984.6 Million INR | 81.901% |
| Achyut Healthcare Limited | 5.73 Million INR | -3008.863% |
| Ajanta Pharma Limited | 8.16 Billion INR | 97.817% |
| Alkem Laboratories Limited | 17.95 Billion INR | 99.008% |
| Alpa Laboratories Limited | 167.76 Million INR | -6.22% |
| Brooks Laboratories Limited | -195.91 Million INR | 190.956% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 88.967% |
| Bajaj HealthCare Limited | -837.93 Million INR | 121.267% |
| Bliss GVS Pharma Limited | 754.54 Million INR | 76.383% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 99.68% |
| Eris Lifesciences Limited | 3.91 Billion INR | 95.454% |
| FDC Limited | 3.05 Billion INR | 94.162% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 101.187% |
| Gufic Biosciences Limited | 861.35 Million INR | 79.312% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 95.767% |
| Ipca Laboratories Limited | 5.47 Billion INR | 96.744% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | 20.67% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 190.327% |
| Lasa Supergenerics Limited | -217.3 Million INR | 182.004% |
| Laurus Labs Limited | 1.6 Billion INR | 88.901% |
| Lupin Limited | 19.14 Billion INR | 99.069% |
| Mankind Pharma Limited | 19.12 Billion INR | 99.068% |
| Medicamen Biotech Limited | 109.31 Million INR | -63.023% |
| Medico Remedies Limited | 82.9 Million INR | -114.934% |
| Megasoft Limited | -127.46 Million INR | 239.802% |
| NATCO Pharma Limited | 13.88 Billion INR | 98.716% |
| RPG Life Sciences Limited | 876.6 Million INR | 79.671% |
| Sigachi Industries Limited | 571.8 Million INR | 68.835% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 99.814% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 94.066% |
| Syncom Formulations (India) Limited | 253.14 Million INR | 29.605% |
| Unichem Laboratories Limited | -704.74 Million INR | 125.286% |
| Wanbury Limited | 559.56 Million INR | 68.154% |
| Windlas Biotech Limited | 581.87 Million INR | 69.375% |
| ZIM Laboratories Limited | 172.46 Million INR | -3.326% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 99.538% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 104.602% |
| Divi's Laboratories Limited | 16 Billion INR | 98.886% |
| Hester Biosciences Limited | 188.89 Million INR | 5.659% |
| Procter & Gamble Health Limited | 2 Billion INR | 91.133% |
| Amrutanjan Health Care Limited | 449.72 Million INR | 60.376% |
| Bal Pharma Limited | 73.92 Million INR | -141.065% |
| Strides Pharma Science Limited | -706.14 Million INR | 125.236% |
| Venus Remedies Limited | 284.9 Million INR | 37.453% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 91.784% |
| Nectar Lifesciences Limited | 49.95 Million INR | -256.757% |
| Shilpa Medicare Limited | 318.74 Million INR | 44.093% |
| Aarti Drugs Limited | 1.71 Billion INR | 89.604% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 86.744% |
| Suven Life Sciences Limited | -1.05 Billion INR | 116.959% |
| Ind-Swift Limited | 142.31 Million INR | -25.217% |
| Valiant Laboratories Limited | 3.19 Million INR | -5475.72% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 96.775% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 103.141% |
| Themis Medicare Limited | 435.23 Million INR | 59.057% |
| Hikal Limited | 696.02 Million INR | 74.397% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 98.924% |
| Sequent Scientific Limited | -358.69 Million INR | 149.681% |
| Novartis India Limited | 851.9 Million INR | 79.082% |
| Wockhardt Limited | -4.63 Billion INR | 103.849% |
| Jubilant Pharmova Limited | 771 Million INR | 76.887% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -2412.69% |
| Neuland Laboratories Limited | 3 Billion INR | 94.062% |
| Morepen Laboratories Limited | 961.59 Million INR | 81.468% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -22.043% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 296.435% |